Search Results

Site Search

Mayo Clinic Labs @Work: Todd Walker - Insights

Todd Walker is a laboratory supervisor for Mayo Clinic Laboratories, Specimen Operations, where he helps lead the department that serves as the gateway between collecting and delivering specimens and getting them processed. Todd credits his...

Research Roundup Archives - Page 2 of 29 - Insights

Skip to Content MayoACCESS MayoLINK...

Research Archives - Page 2 of 33 - Insights

Skip to Content MayoACCESS MayoLINK...

November 2023 - Gastroenterology Pathology Case 2 - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gastroenterology Pathology.

Mayo Clinic Offers New Prostate Cancer Test from Beckman Coulter, Reduces Unnecessary Biopsies - Insights

The prostate health index or phi test reduces the need for prostate cancer biopsies by 30 percent.

April 2023 - Cellular Therapy and Transfusion Medicine - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Cellular Therapy and Transfusion Medicine.

Adrenal disease - Insights

Learn how Mayo Clinic Laboratories testing for adrenal diseases can help physicians detect and classify adrenal disorders.

About us - Insights

At BioPharma Diagnostics, we are inspired by Mayo Clinic’s history of collaboration and breaking down barriers to change medicine. That’s why we bring Mayo Clinic expertise and quality to each project — from consulting through discovery to...

Patient spotlight - Insights

Patients are at the heart of all we do at Mayo Clinic Laboratories. Our laboratory testing can clear the fog of an uncertain diagnosis, point to the next steps in care, and pave the way for better treatment. Our work makes a difference in...

Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. - Insights

Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.